FOLD–G

CONTACT: Investors/Media:         Sara Pellegrino         spellegrino@amicusrx.com         (609) 662-5044                  Media:         Dan Budwick         (973) 271-6085         dan@purecommunicationsinc.com

If you liked this article you might like

Strong Action in Individual Stocks Starts to Feel a Bit Frothy

The Flippers Are at Work and the Bears Are Hopeful

Portola Shares Lower After Pricing Stock Offering - Biotech Movers

Time to Bring Amicus Therapeutics Into the 'FOLD'

Teligent Shares Rise on FDA Approval for Erythromycin Topical Gel